Item 1.02. Termination of a Material Definitive Agreement.

On January 1, 2022, the Share Purchase Agreement (the "Purchase Agreement"), dated June 13, 2021, by and among Avalon GloboCare Corp., a Delaware corporation (the "Company"), on the one hand, and Lonlon Biotech Ltd., a company incorporated in the British Virgin Islands, the holders of the Sen Lang Shares (as defined in the Purchase Agreement) (collectively, "Sen Lang Shareholders"), the beneficial owner of each Sen Lang Shareholder (collectively, the "Sen Lang Beneficial Shareholders" and together with the Sen Lang Shareholders, the "Sen Lang Owners"), and Ding Wei, in his capacity as the Sen Lang Representative (collectively, the "Sen Lang Parties"), on the other hand, was terminated by the Company and the Sen Lang Parties.

Descriptions of the terms of the Purchase Agreement were included in Item 1.01 of the Current Report on Form 8-K filed by the Company on June 14, 2021, and to the extent required by Item 1.02 of Form 8-K, such descriptions are incorporated by reference in this Item 1.02 pursuant to General Instruction B.3 of Form 8-K.




Item 8.01. Other Events.

On January 4, 2022, the Company provided a business update, including with respect to the termination of the Purchase Agreement, a copy of which is furnished as Exhibit 99.1 hereto and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.





Exhibit No.   Description of Exhibit
99.1            Press Release of Avalon GloboCare Corp. dated January 4, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)




                                       1

© Edgar Online, source Glimpses